Patients hospitalized with pneumonia: Determining the need for broad-spectrum antibiotic therapy

Clinical Infectious Diseases

Volumn 54, Issue 4, 2012, Pages 479-482

  Kollef, Marin H ^a   Micek, Scott T ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; CLINICAL DECISION MAKING; COMMUNITY ACQUIRED PNEUMONIA; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NOTE; OBSERVATIONAL STUDY; PATIENT CARE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; PNEUMONIA, BACTERIAL;

EID: 84856741941     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir848     Document Type: Note

References (51)

1. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31:S131-8. (Pubitemid 32291120)
2. Lawrence KL, Kollef MH. Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med 2009; 179:434-8.
3. Aliberti S, Di Pasquale M, Zanaboni AM, et al. Stratifying risk factors for multi-drug resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 2012; 54:470-8.
4. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for healthcare-associated pneumonia. Arch Intern Med 2008; 168:2205-10.
5. Shorr AF, Zilberberg MD, Reichley R, et al. Validation of a clinical score for assessing the risk of resistant pathogens in pneumonia presenting to the emergency department. Clin Infect Dis 2012; 54:193-8.
6. American Thoracic Society, Infectious Diseases Society of America (ATS/IDSA). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
7. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128:3854-62. (Pubitemid 43062645)
8. Kollef MH, Morrow LE, Baughman RP, et al. Healthcare-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes-proceedings of the HCAP summit. Clin Infect Dis 2008; 46:S296-334. (Pubitemid 351590141)
9. Venditti M, Falcone M, Corrao S, Licata G, Serra P. Study Group of the Italian Society of Internal Medicine. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009; 150:19-26.
10. Kollef MH, Napolitano LM, Solomkin JS, et al. Healthcare-associated infection (HAI): a critical appraisal of the emerging threatproceedings of the HAI Summit. Clin Infect Dis 2008; 47:S55-99.
11. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health careassociated pneumonia and communityacquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51:3568-73. (Pubitemid 47519345)
12. Webster D, Chui L, Tyrrell GJ, Marrie TJ. Healthcare-associated Staphylococcus aureus pneumonia. Can J Infect Dis Med Microbiol 2007; 18:181-8.
13. Carratalà J, Mykietiuk A, Fernández-Sabé N, et al. Healthcare-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167:1393-9. (Pubitemid 47052438)
14. Shindo Y, Sato S, Maruyama E, et al. Healthcare-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009; 135:633-40.
15. Rello J, Luján M, Gallego M, et al. Why mortality is increased in healthcare-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest 2010; 137:1138-44.
16. Zilberberg MD, Shorr AF, Micek ST, Mody SH, Kollef MH. Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest 2008; 134: 963-8.
17. Labelle AJ, Arnold H, Reichley RM, Micek ST, Kollef MH. A comparison of culture-positive and culture-negative healthcare-associated pneumonia. Chest 2010; 137:1130-7.
18. Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in non-nosocomial pneumonia and respiratory failure: is it time to refine the definition of healthcare-associated pneumonia? Chest 2010; 137:1283-8.
19. Cecere LM, Rubenfeld GD, Park DR, Root RK, Goss CH. Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia. Respiration 2010; 79:128-36.
20. Chalmers JD, Taylor JK, Singanayagam A, et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 2011; 15:107-13.
21. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44:S27-72. (Pubitemid 46290553)
22. Seymann GB, Di Francesco L, Sharpe B, et al. The HCAP gap: differences between self-reported practice patterns and published guidelines for health care-associated pneumonia. Clin Infect Dis 2009; 49:1868-74.
23. Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010; 10:279-87.
24. Grenier C, Pépin J, Nault V, et al. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J Antimicrob Chemother 2011; 66:1617-24.
25. Garcia-Vidal C, Viasus D, Roset A, et al. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 2011; 14:1659-65.
26. Micek ST, Kollef MH. Health care-associated pneumonia (HCAP): Empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal putcome. Medicine 2011; 90:390-5.
27. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical superchallenge. N Engl J Med 2009; 360:439-43.
28. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006; 166: 1945-51. (Pubitemid 44537174)
29. Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001; 32:1393-8. (Pubitemid 32424271)
30. Marschall J, Mühlemann K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol 2006; 27:1206-12. (Pubitemid 44807464)
31. Huang SS, Hinrichsen VL, Datta R, et al. Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detection. PLoS One 2011; 6:e24340.
32. Datta R, Huang SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 2008; 47:176-81. (Pubitemid 351920617)
33. Friedmann R, Raveh D, Zartzer E, et al. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009; 30:534-42.
34. Zahar JR, Lanternier F, Mechai F, et al. Duration of colonisation by Enterobacteriaceae producing extended-spectrum beta-lactamase and risk factors for persistent faecal carriage. J Hosp Infect 2010; 75:76-8.
35. Manzur A, Gudiol F. Methicillin-resistant Staphylococcus aureus in long-term-care facilities. Clin Microbiol Infect 2009; 15:26-30.
36. Pop-Vicas AE, D'Agata EM. The rising influx of multidrug-resistant gram negative bacilli into a tertiary care hospital. Clin Infect Dis 2005; 40:1792-8. (Pubitemid 40799949)
37. Flamm RK, Weaver MK, Thornsberry C, Jones ME, Karlowsky JA, Sahm DF. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother 2004; 48:2431-6. (Pubitemid 38823407)
38. Won SY, Munoz-Price LS, Lolans K, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemaseproducing Enterobacteriaceae. Clin Infect Dis 2011; 53:532-40.
39. Bradley SF, Terpenning MS, Ramsey MA, et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a longterm-care facility. Ann Intern Med 1991; 115:417-22.
40. Muder RR, Brennen C, Wagener MM, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991; 114:107-12.
41. Barr B, Wilcox MH, Brady A, Parnell P, Darby B, Tompkins D. Prevalence of methicillin-resistant Staphylococcus aureus colonization among older residents of care homes in the United Kingdom. Infect Control Hosp Epidemiol 2007; 28:853-9. (Pubitemid 47055926)
42. Talon DR, Bertrand X. Methicillin-resistant Staphylococcus aureus in geriatric patients: usefulness of screening in a chronic-care setting. Infect Control Hosp Epidemiol 2001; 22:505-9. (Pubitemid 33031710)
43. Manzur A, Gavalda L, Ruiz de Gopegui E, et al. Prevalence of methicillin-resistant Staphylococcus aureus and factors associated with colonization among residents in community long-term care facilities in Spain. Clin Microbiol Infect 2008; 18:867-72.
44. Cretnik TZ, Vovko P, Retelj M, et al. Prevalence and nosocomial spread of methicillin-resistant Staphylococcus aureus in a long-term-care facility in Slovenia. Infect Control Hosp Epidemiol 2005; 26: 184-90. (Pubitemid 40445024)
45. O'Sullivan NP, Keane CT. The prevalence of methicillin-resistant Staphylococcus aureus among the residents of six nursing homes for the elderly. J Hosp Infect 2000; 45:322-9. (Pubitemid 30645078)
46. Pop-Vicas A, Mitchell SL, Kandel R, Schreiber R, D'Agata EM. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 2008; 56:1276-80.
47. O'Fallon E, Gautam S, D'Agata EM. Colonization with multidrug-resistant gram-negative bacteria: prolonged duration and frequent cocolonization. Clin Infect Dis 2009; 48: 1375-81.
48. Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, Kaye KS. Multidrugresistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 2010; 50:1611-16.
49. March A, Aschbacher R, Dhanji H, et al. Colonization of residents and staff of a longterm-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect 2010; 16:934-44.
50. El Solh AA, Pietrantoni C, Bhat A, Bhora M, Berbary E. Indicators of potentially drugresistant bacteria in severe nursing homeacquired pneumonia. Clin Infect Dis 2004; 39:474-80. (Pubitemid 39120921)
51. Chung DR, Song JH, Kim SH, et al. High prevalence of multidrug-desistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 2011; [Epub ahead of print].